Novo Nordisk said on Wednesday it had agreed a price under the U.S. Medicare scheme for semaglutide, the active ingredient in ...
Intensifying competition, pricing pressure and copycat versions of Ozempic and Wegovy hold back sales at the pharma giant.
As Ozempic use rises, society’s obsession with thinness is erasing body positivity and real, authentic bodies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback